Advertisement
News
Subscribe to Pharmaceutical Processing News

The Lead

Drug R&D Costs: $1.7 Billion And Rising

April 20, 2015 | by Institute For Policy Innovation | Comments

Growing costs have been attributed to a slow FDA, drug complexity, and short patent life.

TOPICS:

ChemoCentryx Initiates Clinical Trial of Its Next-Generation CCR2 Inhibitor in Pancreatic Cancer

April 20, 2015 10:19 am | by Globe Newswire | Comments

CCX872 is the company's second clinical compound which is an orally administered inhibitor of the chemokine receptor known as CCR2.

TOPICS:

Study Reveals Potential Treatment for Soldiers' Internal Injuries

April 17, 2015 4:55 pm | by Andy Szal, Digital Reporter | Comments

Explosions account for nearly 80 percent of today's combat-related injuries, and subsequent internal bleeding could prove fatal without quick intervention.

TOPICS:

With Biosimilar Drug Development on The Rise, Researchers Explore Efficacy

April 17, 2015 4:51 pm | by Future Science Group | Comments

Immunotherapy review explores key questions on how biosimilar drug likenesses and differences will impact patient treatments.

TOPICS:
Advertisement

Glaxo Recalls Flu Vaccine Due to Potency Problem

April 17, 2015 3:37 pm | by MATTHEW PERRONE, AP Health Writer | Comments

The company alerted U.S. customers Tuesday that the vaccine can lose potency and fail to adequately protect against some strains of the flu.

TOPICS:

Survey: More Than Half of Older Adults in The US Now Taking Aspirin

April 17, 2015 3:05 pm | by Oregon State University | Comments

More than half of the older adults in the United States are now taking a daily dose of aspirin, even though its use is not recommended by the Food and Drug Administration for most people who have not yet had a heart attack or stroke.

TOPICS:

USDA Veterinarian: Bird Flu Outbreak Could be 'Devastating'

April 17, 2015 3:02 pm | by STEVE KARNOWSKI, Associated Press | Comments

The nation's poultry industry may have to live with a deadly bird flu strain for several years, which would be "devastating," the U.S. Department of Agriculture's chief veterinary officer said Thursday.

TOPICS:

Fed Grant for Pain-Free Blood Test Startup at UW

April 17, 2015 12:32 pm | by University of Wisconsin - Madison | Comments

A company with deep roots at the University of Wisconsin-Madison wants to make blood sampling less painful and more convenient.

TOPICS:

Merck CEO Frazier Becomes PhRMA Board Chairman

April 17, 2015 12:25 pm | Comments

Kenneth C. Frazier, chairman and CEO of Merck & Co., Inc., was elected chairman of the Board of the Pharmaceutical Research and Manufacturers of America (PhRMA).

TOPICS:
Advertisement

FDA Approves First Generic To Treat MS

April 17, 2015 12:16 pm | by FDA | Comments

The U.S. Food and Drug Administration today approved the first generic version of Copaxone (glatiramer acetate injection), used to treat patients with relapsing forms of multiple sclerosis (MS).

TOPICS:

Sartorius Stedim Biotech Acquires BioOutsource

April 17, 2015 12:10 pm | by Sartorius Stedim Biotech Group | Comments

Sartorius Stedim Biotech (SSB), an international supplier for the biopharmaceutical industries, today acquired the Scottish company BioOutsource Ltd.

TOPICS:

PhRMA Applauds 2015 We Work For Health Award Winners

April 17, 2015 12:03 pm | by Pharmaceutical Research and Manufacturers of America (PhRMA) | Comments

PhRMA honored 13 employees from 12 biopharmaceutical companies as “We Work For Health Champions” for their extraordinary efforts in policy advocacy and community service.

TOPICS:

Physicians Want Dr. Oz Gone From Columbia Medical Faculty

April 17, 2015 10:53 am | by Verena Dobnik, Associated Press | Comments

A group of top doctors has demanded Columbia University remove Dr. Oz, citing his "egregious lack of integrity" for promoting what they call "quack treatments."

TOPICS:

CollabRx and Medytox Solutions Sign Definitive Merger Agreement

April 16, 2015 3:47 pm | by Globe Newswire | Comments

Medytox currently owns and operates several healthcare companies, including clinical testing laboratories, an electronic medical records provider, a laboratory information systems company and a medical billing company. CollabRx is a leading informatics company focused on the interpretation of complex molecular and genetic tests in cancer.

TOPICS:

Sagent Pharmaceuticals Appoints Michael Logerfo as President

April 16, 2015 3:39 pm | by Globe Newswire | Comments

Sagent Pharmaceuticals, Inc., a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced that its current EVP and Chief Legal Officer Michael Logerfo has been appointed President.

TOPICS:

U.S. Marshals Seize Unapproved Drugs From Florida Distributor

April 16, 2015 3:31 pm | by FDA.gov | Comments

Stratus Pharmaceuticals marketed and distributed unapproved prescription drug products that were manufactured by Sonar Products, Inc., of Carlstadt, New Jersey.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading